Lantern Pharma prices private placement warrants to buy 3,669,725 shares at $1.09 each
LTRN•Lantern Pharma priced warrants to buy up to 3,669,725 shares at $1.09 each, potentially generating about $4 million if fully exercised for cash. The closing is expected around Sept. 30, 2026, alongside a $4 million registered direct offering priced at $1.09 per share.
1. Warrant terms
Lantern Pharma priced a private placement of unregistered warrants to buy up to 3,669,725 common shares at an exercise price of $1.09. The warrants may be exercised only after stockholder approval and have a five-year term from approval. Full cash exercise would generate about $4 million, though there is no assurance the warrants will be exercised.
2. Expected closing
The closing is expected around Sept. 30, 2026, alongside a $4 million registered direct offering priced at $1.09 per share.
